Clinical Investigation Evaluating the Safety and Feasibility of Adipearl

A Single-Arm, Prospective, Clinical Investigation Evaluating the Safety and Feasibility of Adipearl Implantation in the Face of Adult Subjects

Status

Active, not recruiting

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT06034522

Enrollment

Registered

2023-09-13

Start date

2023-11-25

Completion date

2026-11-30

Last updated

2025-09-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mid-face Volume Deficiency

Brief summary

Adipearl is an injectable filler intended to be injected subcutaneously in the face.

Interventions

DEVICEAdipearl

Injection of the investigational device in the face.

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

BASIC_SCIENCE

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

22 Years to 65 Years

Healthy volunteers

Yes

Inclusion criteria

* Subject having given freely and expressly informed consent; * Subject deemed by the Investigator to be medically fit for injection of the product; * Female or male subjects aged 22 to 65 years (inclusive);

Exclusion criteria

* Pregnant or nursing woman or planning a pregnancy during the study. * Subject who had been deprived of their freedom by administrative or legal decision or who is under guardianship. * Subject participating to another research study. * Subject with the presence of any condition, which in the opinion of the Principal Investigator, that makes her/him unable to complete the study per protocol.

Design outcomes

Primary

Measure	Time frame	Description
Safety of Investigational Medical Device	Up to 6 months	Collection of Injection Site Reactions and Adverse Events during the study.

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026